Valeria A. Glazunova
Research Subjects
Valeria A. Glazunova has a total of 88 co-authors. Here are the top co-authors by number of shared publications:
- Alexander Albertovich Shtil
Blokhin National Medical Research Center of Oncology, Russia
11 shared publications - Andrey Egorovich Shchekotikhin
Gause Institute of New Antibiotics, Moscow, Russia
6 shared publications - Maria N. Preobrazhenskaya
Gause Institute of New Antibiotics, Russian Academy of Medical Sciences, Moscow 119021, Russia
6 shared publications Lyubov G. Dezhenkova
Gause Institute of New Antibiotics , 11 Bolshaya Pirogovskaya Street, Moscow 119021, Russia
5 shared publicationsJan Balzarini
Rega Institute for Medical Research, Katholieke Universiteit Leuven , 3000 Leuven, Belgium
4 shared publicationsVladimir N. Buyanov
Mendeleyev University of Chemical Technology, 9 Miusskaya Square, Moscow 125190, Russia
4 shared publications
Latest Publications
- 15 December 2015
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 58 (24) , 9522-9534
Synthesis and Characterization of 4,11-Diaminoanthra[2,3-b]furan-5,10-diones: Tumor Cell Apoptosis through tNOX-Modulated NAD+/NADH Ratio and SIRT1
A series of new 4,11-diaminoanthra[2,3-b]furan-5,10-dione derivatives with different side chains were synthesized. Selected 2-unsubstituted derivatives 11–14 showed high antiproliferative potency on a panel of mammalian tumor cell lines including multidrug resistance variants. Compounds 11–14 utilized multiple mechanisms of cytotoxicity including inhibition of Top1/Top2-mediated DNA relaxation, reduced NAD+/NADH ratio through tNOX inhibition, suppression of a NAD+-dependent sirtuin 1 (SIRT1) deacetylase activity, and activation of caspase-mediated apoptosis. Here, for the first time, we report that tumor-associated NADH oxidase (tNOX) and SIRT1 are important cellular targets of antitumor anthracene-9,10-diones.
- 15 December 2015
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 58 (24) , 9522-9534
Synthesis and Characterization of 4,11-Diaminoanthra[2,3-b]furan-5,10-diones: Tumor Cell Apoptosis through tNOX-Modulated NAD+/NADH Ratio and SIRT1
A series of new 4,11-diaminoanthra[2,3-b]furan-5,10-dione derivatives with different side chains were synthesized. Selected 2-unsubstituted derivatives 11–14 showed high antiproliferative potency on a panel of mammalian tumor cell lines including multidrug resistance variants. Compounds 11–14 utilized multiple mechanisms of cytotoxicity including inhibition of Top1/Top2-mediated DNA relaxation, reduced NAD+/NADH ratio through tNOX inhibition, suppression of a NAD+-dependent sirtuin 1 (SIRT1) deacetylase activity, and activation of caspase-mediated apoptosis. Here, for the first time, we report that tumor-associated NADH oxidase (tNOX) and SIRT1 are important cellular targets of antitumor anthracene-9,10-diones.
- 1 October 2014
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 86, 797-805
Synthesis and evaluation of new antitumor 3-aminomethyl-4,11-dihydroxynaphtho[2,3-f]indole-5,10-diones
- 1 October 2014
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 86, 797-805
Synthesis and evaluation of new antitumor 3-aminomethyl-4,11-dihydroxynaphtho[2,3-f]indole-5,10-diones
- 8 August 2014
- Published by Taylor & Francis in Nucleosides, Nucleotides & Nucleic Acids
- Vol. 33 (9) , 615-625
Novel Fluorescent Pyrimidine Nucleosides Containing 2,1,3-Benzoxadiazole and Naphtho-[1,2,3-CD] Indole-6 (2H)-One Fragments
A series of novel fluorescent pyrimidine nucleosides containing 2,1,3-benzoxadiazole or naphtho[1,2,3-cd]indole-6 (2h)-one fragments was designed and synthesized. Introduction of fluorescent fragments into the position 5 of the uridine or cytidine heterocycle was carried out in two ways: by Sonogashira Coupling Reaction and CuI-catalyzed cycloaddition ("click" reaction). The obtained nucleoside derivatives became fluorescent due to the inserted fragments. The excitation wavelength (440-450 nm) was outside the absorption band of many biomolecules and significantly differed from the emission wavelength (560-600 nm). In addition, the intended nucleoside analogs were shown to kill cultured human tumor cells at submicromolar concentrations.
- 8 August 2014
- Published by Taylor & Francis in Nucleosides, Nucleotides & Nucleic Acids
- Vol. 33 (9) , 615-625
Novel Fluorescent Pyrimidine Nucleosides Containing 2,1,3-Benzoxadiazole and Naphtho-[1,2,3-CD] Indole-6 (2H)-One Fragments
A series of novel fluorescent pyrimidine nucleosides containing 2,1,3-benzoxadiazole or naphtho[1,2,3-cd]indole-6 (2h)-one fragments was designed and synthesized. Introduction of fluorescent fragments into the position 5 of the uridine or cytidine heterocycle was carried out in two ways: by Sonogashira Coupling Reaction and CuI-catalyzed cycloaddition ("click" reaction). The obtained nucleoside derivatives became fluorescent due to the inserted fragments. The excitation wavelength (440-450 nm) was outside the absorption band of many biomolecules and significantly differed from the emission wavelength (560-600 nm). In addition, the intended nucleoside analogs were shown to kill cultured human tumor cells at submicromolar concentrations.
- Open Access
- 15 September 2013
- Published by Acta Naturae Ltd in Acta Naturae
- Vol. 5 (3) , 74-78
Acadesine Triggers Non-apoptotic Death in Tumor Cells
We studied the cytotoxicity of acadesine (5-aminoimidazole-4-carboxamide-1--D-ribofuranoside) for tumor and normal cells of various species and tissue origin. In tumor cells, acadesine triggered non-apoptotic death; the potency of the compound to normal cells was substantially lower. Acadesine was toxic for tumor cells with multidrug resistant phenotypes caused by the transmembrane transporter Р-glycoprotein or lack of proapoptotic p53. Activity of adenosine receptors was required for acadesine-induced cell death, whereas functioning of АМР-dependent protein kinase was not required. A more pronounced cytotoxicity for tumor cells, as well as the non-canonical death mechanism(s), makes acadesine a promising candidate for antitumor therapy.
- 15 September 2013
- Published by Acta Naturae Ltd in Acta Naturae
- Vol. 5 (3) , 74-78
Open AccessAcadesine Triggers Non-apoptotic Death in Tumor Cells
We studied the cytotoxicity of acadesine (5-aminoimidazole-4-carboxamide-1--D-ribofuranoside) for tumor and normal cells of various species and tissue origin. In tumor cells, acadesine triggered non-apoptotic death; the potency of the compound to normal cells was substantially lower. Acadesine was toxic for tumor cells with multidrug resistant phenotypes caused by the transmembrane transporter Р-glycoprotein or lack of proapoptotic p53. Activity of adenosine receptors was required for acadesine-induced cell death, whereas functioning of АМР-dependent protein kinase was not required. A more pronounced cytotoxicity for tumor cells, as well as the non-canonical death mechanism(s), makes acadesine a promising candidate for antitumor therapy.
- 1 October 2012
- Published by Springer Nature in Bulletin of Experimental Biology and Medicine
- Vol. 153 (6) , 879-882
Expression of Peroxiredoxin 1, 2, 3, and 6 Genes in Cancer Cells during Drug Resistance Formation
We studied the expression of peroxiredoxin genes (PRDX1, PRDX2, PRDX3, and PRDX6) in human erythroleukemia K652, human breast carcinoma MCF-7, and human ovarian carcinoma SKOV-3 cells during cisplatin resistance development. It was found that drug resistance formation was accompanied by a significant increase in the expression of PRDX1, PRDX2, PRDX3, PRDX6 genes in all cancer cell strains, which confirms the important contribution of redox-dependent mechanisms into the development of cisplatin resistance of cancer cells.
- 1 October 2012
- Published by Springer Nature in Bulletin of Experimental Biology and Medicine
- Vol. 153 (6) , 879-882
Expression of Peroxiredoxin 1, 2, 3, and 6 Genes in Cancer Cells during Drug Resistance Formation
We studied the expression of peroxiredoxin genes (PRDX1, PRDX2, PRDX3, and PRDX6) in human erythroleukemia K652, human breast carcinoma MCF-7, and human ovarian carcinoma SKOV-3 cells during cisplatin resistance development. It was found that drug resistance formation was accompanied by a significant increase in the expression of PRDX1, PRDX2, PRDX3, PRDX6 genes in all cancer cell strains, which confirms the important contribution of redox-dependent mechanisms into the development of cisplatin resistance of cancer cells.
- 1 January 2011
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 46 (1) , 423-428
The first series of 4,11-bis[(2-aminoethyl)amino]anthra[2,3-b]furan-5,10-diones: Synthesis and anti-proliferative characteristics
- 1 January 2011
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 46 (1) , 423-428
The first series of 4,11-bis[(2-aminoethyl)amino]anthra[2,3-b]furan-5,10-diones: Synthesis and anti-proliferative characteristics
- 1 December 2010
- Published by Springer Nature in Russian Chemical Bulletin
- Vol. 59 (12) , 2259-2267
Tris(1-alkylindol-3-yl)methylium salts as a novel class of antitumor agents
- 1 December 2010
- Published by Springer Nature in Russian Chemical Bulletin
- Vol. 59 (12) , 2259-2267
Tris(1-alkylindol-3-yl)methylium salts as a novel class of antitumor agents
- 20 November 2010
- Vol. 72 (4) , 24-7
[Are human papillomaviruses responsible for the occurrence of bladder cancer].
A female patient with recurrent bladder cancer underwent complex examination. The primary tumor removed in 2004 showed human papillomavirus (HPV) 16 DNA, mRNA corresponding to HPV16 oncogene E7, as well as HPV16 protein E7. The patient is a smoker who has been working at a chemical factory for over 20 years. During tumor recurrence in 2009, there was no DNA of high-risk HPV types in the cancer cells. HPV16 E7protein and cellular p 16(INK4alpha), an indicator of HPV-induced carcinogenesis, were not found. Colposcopy revealed no precancerous changes in the epithelium of the cervix uteri. The cervical epitheliocytes contained no high-risk HPV DNA, E7 and p16(INK4alpha) proteins. It seems expedient to continue in vitro studies of the possible role of HPV in urothelial carcinogenesis on an experimental model.
- 20 November 2010
- Vol. 72 (4) , 24-7
[Are human papillomaviruses responsible for the occurrence of bladder cancer].
A female patient with recurrent bladder cancer underwent complex examination. The primary tumor removed in 2004 showed human papillomavirus (HPV) 16 DNA, mRNA corresponding to HPV16 oncogene E7, as well as HPV16 protein E7. The patient is a smoker who has been working at a chemical factory for over 20 years. During tumor recurrence in 2009, there was no DNA of high-risk HPV types in the cancer cells. HPV16 E7protein and cellular p 16(INK4alpha), an indicator of HPV-induced carcinogenesis, were not found. Colposcopy revealed no precancerous changes in the epithelium of the cervix uteri. The cervical epitheliocytes contained no high-risk HPV DNA, E7 and p16(INK4alpha) proteins. It seems expedient to continue in vitro studies of the possible role of HPV in urothelial carcinogenesis on an experimental model.
- 1 September 2010
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 18 (18) , 6905-6913
Synthesis and cytotoxic potency of novel tris(1-alkylindol-3-yl)methylium salts: Role of N-alkyl substituents
- 1 September 2010
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 18 (18) , 6905-6913
Synthesis and cytotoxic potency of novel tris(1-alkylindol-3-yl)methylium salts: Role of N-alkyl substituents
- 20 July 2010
- Published by Springer Nature in Bulletin of Experimental Biology and Medicine
- Vol. 149 (2) , 242-245
Cellular Expression of INK4a Gene in Cells of Bladder Cancer Associated with Human Papilloma Virus-16
- 20 July 2010
- Published by Springer Nature in Bulletin of Experimental Biology and Medicine
- Vol. 149 (2) , 242-245
Cellular Expression of INK4a Gene in Cells of Bladder Cancer Associated with Human Papilloma Virus-16